Elanco Animal Health Inc 4

Elanco CEO Jeffrey N. Simmons received an award of 117.9362 deferred stock units (share equivalents) valued at roughly $2,800.

On August 21, 2026, Elanco Animal Health Inc. President, CEO and Director Jeffrey N. Simmons received 117.9362 deferred stock units, which correspond to an equal number of shares of Elanco common stock or their cash equivalent, at an implied price of approximately $23.97 per share, for an aggregate value of about $2,827. These units were awarded under the company’s Executive Deferral and Stock Match Plan and will settle in cash or stock following his termination of employment or during a specified future year. Following this award, Simmons beneficially owned 25,130.1237 shares (or share-equivalents) on a direct basis, with an estimated value of roughly $627,000 based on the current market price of $24.94 per share.

Filing Facts

CIK

1739104

Ticker

ELAN

Form

4

Source Type

fda

Accession

0001479079-26-000039

Alert Tier

4